These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4871404)

  • 1. Impairment of delayed hypersensitivity in uremic patients by antilymphocyte serum.
    Brunstetter FH
    Transplantation; 1968 May; 6(3):485-7. PubMed ID: 4871404
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro cellular immunity and in vivo delayed hypersensitivity in uremic patients maintained on hemodialysis.
    Sengar DP; Rashid A; Harris JE
    Int Arch Allergy Appl Immunol; 1974; 47(6):829-38. PubMed ID: 4279227
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunologic capability of uremic patients.
    Merrill JP
    Cancer Res; 1968 Jul; 28(7):1449-51. PubMed ID: 4874991
    [No Abstract]   [Full Text] [Related]  

  • 4. [The anti-lymphocyte serum].
    Halpern B
    Rev Fr Odontostomatol; 1969 Apr; 16(4):515-22. PubMed ID: 4184525
    [No Abstract]   [Full Text] [Related]  

  • 5. The preparation and properties of anti-lymphocytic sera.
    James K
    Prog Surg; 1969; 7():140-217. PubMed ID: 4183661
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity.
    Huber H; Pastner D; Dittrich P; Braunsteiner H
    Clin Exp Immunol; 1969 Jul; 5(1):75-82. PubMed ID: 5789563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.
    Kashiwagi N; Brantigan CO; Brettschneider L; Groth CG; Starzl TE
    Ann Intern Med; 1968 Feb; 68(2):275-86. PubMed ID: 4181614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic patients immunized with planned blood transfusions: detection of HLA antibodies with the cytotoxic test and an indirect rosette microassay.
    Indiveri F; Fagiolo U; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Mar; 11(1):167-70. PubMed ID: 377624
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxicity of human lymphocytes: antagonism between inducing processes.
    Lundgren G; Collste L; Möller G
    Nature; 1968 Oct; 220(5164):289-91. PubMed ID: 4879327
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of immunocompetency by DNCB sensitization prior to human renal allotransplantation.
    Rolley RT; Sterioff S; Williams GM; Parks LC
    Surg Forum; 1974; 25(0):268-70. PubMed ID: 4155131
    [No Abstract]   [Full Text] [Related]  

  • 11. Depletion of lymphocytes for the protection of renal allografts.
    Sarles HE; Remmers AR; Fish JC; Canales CO; Thomas FD; Tyson KR; Beathard GA; Ritzmann SE
    Arch Intern Med; 1970 Mar; 125(3):443-50. PubMed ID: 4190497
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hemodialysis and transplantation on inhibition of lymphocyte transformation by sera from uremic patients.
    Nelson DS; Penrose JM
    Clin Immunol Immunopathol; 1975 May; 4(1):143-6. PubMed ID: 1092497
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of specific, potent antilymphocyte serum in the horse using dog thymocytes.
    Braf ZF; Smellie WA; Williams GM; Hume DM
    Surg Forum; 1967; 18():227-9. PubMed ID: 4866923
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive properties of the antilymphocytic serum].
    Zablocki B
    Pol Arch Med Wewn; 1969 Feb; 42(2):137-42. PubMed ID: 4894576
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preparation, properties and activities of a horse anti-human lymphocyte serum].
    Traeger J; Carraz M; Fries D; Perrin J; Saubier E; Brochier J; Bernhardt JP; Archimbaud JP; Bonnet P; Veyssere C; Prevot R; Traeger-Fouillet Y; Bryon PA; Manuel Y
    Pathol Biol; 1968 Jan; 16(1):27-39. PubMed ID: 4869418
    [No Abstract]   [Full Text] [Related]  

  • 16. Antilymphocyte serum potentiation of candida keratitis.
    Smolin G; Okumoto M
    Am J Ophthalmol; 1968 Nov; 66(5):804-12. PubMed ID: 5686910
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of intermittent hemodialysis on the immune response of potential renal allograft recipients, and its correlation with allograft survival.
    Rashid A; Sengar DP; Couture RA; Posen GA; Harris JE
    Trans Am Soc Artif Intern Organs; 1974; 20 B():557-61. PubMed ID: 4615413
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of the xenogeneic and allogeneic components of bivalent rabbit antilymphocyte serum.
    Stewart PB; Cohen V; Bell R
    Nature; 1969 May; 222(5193):592-3. PubMed ID: 4889309
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective suppression of cellular immunity by antilymphocyte serum.
    Lance EM; Batchelor JR
    Transplantation; 1968 May; 6(3):490-1. PubMed ID: 4871405
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of DNA synthesis in lymphocytes from ALG-treated patients.
    Möller G; Lundgren G
    Clin Exp Immunol; 1970 Feb; 6(2):299-304. PubMed ID: 4907964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.